nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—ABCG2—primary biliary cirrhosis	0.319	1	CbGaD
Ponatinib—ABCB11—Ursodeoxycholic acid—primary biliary cirrhosis	0.222	0.662	CbGbCtD
Ponatinib—CYP2C8—Colchicine—primary biliary cirrhosis	0.0393	0.117	CbGbCtD
Ponatinib—ABCB11—bile canaliculus—primary biliary cirrhosis	0.0361	0.411	CbGeAlD
Ponatinib—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0315	0.094	CbGbCtD
Ponatinib—ABCB1—Colchicine—primary biliary cirrhosis	0.0266	0.0794	CbGbCtD
Ponatinib—CYP3A4—Colchicine—primary biliary cirrhosis	0.0159	0.0475	CbGbCtD
Ponatinib—ABCB11—bile duct—primary biliary cirrhosis	0.0113	0.128	CbGeAlD
Ponatinib—ABCB11—bile—primary biliary cirrhosis	0.00866	0.0986	CbGeAlD
Ponatinib—Pericardial effusion—Ursodeoxycholic acid—primary biliary cirrhosis	0.0025	0.0194	CcSEcCtD
Ponatinib—Pericardial effusion—Chenodeoxycholic acid—primary biliary cirrhosis	0.0025	0.0194	CcSEcCtD
Ponatinib—Myelosuppression—Colchicine—primary biliary cirrhosis	0.00244	0.0189	CcSEcCtD
Ponatinib—PDGFRA—gall bladder—primary biliary cirrhosis	0.00203	0.0231	CbGeAlD
Ponatinib—Blood glucose increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00201	0.0156	CcSEcCtD
Ponatinib—Blood glucose increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00201	0.0156	CcSEcCtD
Ponatinib—FGFR3—epithelium—primary biliary cirrhosis	0.00185	0.021	CbGeAlD
Ponatinib—KIT—gall bladder—primary biliary cirrhosis	0.00162	0.0185	CbGeAlD
Ponatinib—FGFR4—liver—primary biliary cirrhosis	0.00154	0.0175	CbGeAlD
Ponatinib—Pleural effusion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00134	0.0104	CcSEcCtD
Ponatinib—Pleural effusion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00134	0.0104	CcSEcCtD
Ponatinib—RET—epithelium—primary biliary cirrhosis	0.00127	0.0145	CbGeAlD
Ponatinib—Gamma-glutamyltransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00969	CcSEcCtD
Ponatinib—Gamma-glutamyltransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00969	CcSEcCtD
Ponatinib—FGFR2—epithelium—primary biliary cirrhosis	0.00121	0.0138	CbGeAlD
Ponatinib—Creatinine increased—Colchicine—primary biliary cirrhosis	0.0012	0.00933	CcSEcCtD
Ponatinib—Cardiovascular disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00908	CcSEcCtD
Ponatinib—Cardiovascular disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00908	CcSEcCtD
Ponatinib—FGFR2—smooth muscle tissue—primary biliary cirrhosis	0.00117	0.0133	CbGeAlD
Ponatinib—TEK—epithelium—primary biliary cirrhosis	0.00116	0.0132	CbGeAlD
Ponatinib—Nilotinib—ABCG2—primary biliary cirrhosis	0.00114	0.455	CrCbGaD
Ponatinib—Cellulitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00877	CcSEcCtD
Ponatinib—Cellulitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00877	CcSEcCtD
Ponatinib—TEK—smooth muscle tissue—primary biliary cirrhosis	0.00112	0.0127	CbGeAlD
Ponatinib—Blood bilirubin increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00843	CcSEcCtD
Ponatinib—Blood bilirubin increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00843	CcSEcCtD
Ponatinib—Creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00838	CcSEcCtD
Ponatinib—Creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00838	CcSEcCtD
Ponatinib—Bone pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00833	CcSEcCtD
Ponatinib—Bone pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00833	CcSEcCtD
Ponatinib—LYN—liver—primary biliary cirrhosis	0.00105	0.012	CbGeAlD
Ponatinib—FGFR3—liver—primary biliary cirrhosis	0.00105	0.0119	CbGeAlD
Ponatinib—Neck pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00104	0.00807	CcSEcCtD
Ponatinib—Musculoskeletal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00104	0.00807	CcSEcCtD
Ponatinib—Musculoskeletal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00104	0.00807	CcSEcCtD
Ponatinib—Neck pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00104	0.00807	CcSEcCtD
Ponatinib—SRC—epithelium—primary biliary cirrhosis	0.00103	0.0117	CbGeAlD
Ponatinib—PDGFRA—smooth muscle tissue—primary biliary cirrhosis	0.00101	0.0115	CbGeAlD
Ponatinib—Influenza like illness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000997	0.00775	CcSEcCtD
Ponatinib—Influenza like illness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000997	0.00775	CcSEcCtD
Ponatinib—SRC—smooth muscle tissue—primary biliary cirrhosis	0.000993	0.0113	CbGeAlD
Ponatinib—Fluid retention—Chenodeoxycholic acid—primary biliary cirrhosis	0.000975	0.00757	CcSEcCtD
Ponatinib—Fluid retention—Ursodeoxycholic acid—primary biliary cirrhosis	0.000975	0.00757	CcSEcCtD
Ponatinib—Imatinib—ABCG2—primary biliary cirrhosis	0.00095	0.38	CrCbGaD
Ponatinib—KDR—epithelium—primary biliary cirrhosis	0.000948	0.0108	CbGeAlD
Ponatinib—Ecchymosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000928	0.00721	CcSEcCtD
Ponatinib—Ecchymosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000928	0.00721	CcSEcCtD
Ponatinib—KDR—smooth muscle tissue—primary biliary cirrhosis	0.000914	0.0104	CbGeAlD
Ponatinib—BCR—liver—primary biliary cirrhosis	0.000906	0.0103	CbGeAlD
Ponatinib—FLT3—liver—primary biliary cirrhosis	0.0009	0.0102	CbGeAlD
Ponatinib—Blood alkaline phosphatase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000857	0.00666	CcSEcCtD
Ponatinib—Blood alkaline phosphatase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000857	0.00666	CcSEcCtD
Ponatinib—KIT—epithelium—primary biliary cirrhosis	0.00084	0.00957	CbGeAlD
Ponatinib—Gastrointestinal haemorrhage—Colchicine—primary biliary cirrhosis	0.00083	0.00644	CcSEcCtD
Ponatinib—Cardiac failure congestive—Ursodeoxycholic acid—primary biliary cirrhosis	0.000822	0.00638	CcSEcCtD
Ponatinib—Cardiac failure congestive—Chenodeoxycholic acid—primary biliary cirrhosis	0.000822	0.00638	CcSEcCtD
Ponatinib—KIT—smooth muscle tissue—primary biliary cirrhosis	0.00081	0.00922	CbGeAlD
Ponatinib—FGFR1—liver—primary biliary cirrhosis	0.000807	0.00918	CbGeAlD
Ponatinib—Atrial fibrillation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000787	0.00611	CcSEcCtD
Ponatinib—Atrial fibrillation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000787	0.00611	CcSEcCtD
Ponatinib—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.000777	0.00604	CcSEcCtD
Ponatinib—Dehydration—Colchicine—primary biliary cirrhosis	0.000771	0.00599	CcSEcCtD
Ponatinib—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000764	0.00593	CcSEcCtD
Ponatinib—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000764	0.00593	CcSEcCtD
Ponatinib—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.000761	0.00591	CcSEcCtD
Ponatinib—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.000761	0.00591	CcSEcCtD
Ponatinib—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.000747	0.0058	CcSEcCtD
Ponatinib—Gastrointestinal haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000745	0.00579	CcSEcCtD
Ponatinib—Gastrointestinal haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000745	0.00579	CcSEcCtD
Ponatinib—Migraine—Chenodeoxycholic acid—primary biliary cirrhosis	0.000734	0.0057	CcSEcCtD
Ponatinib—Migraine—Ursodeoxycholic acid—primary biliary cirrhosis	0.000734	0.0057	CcSEcCtD
Ponatinib—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.000732	0.00568	CcSEcCtD
Ponatinib—LCK—liver—primary biliary cirrhosis	0.000722	0.00822	CbGeAlD
Ponatinib—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00072	0.00559	CcSEcCtD
Ponatinib—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00072	0.00559	CcSEcCtD
Ponatinib—ABCB11—liver—primary biliary cirrhosis	0.000705	0.00803	CbGeAlD
Ponatinib—ABL1—smooth muscle tissue—primary biliary cirrhosis	0.000705	0.00802	CbGeAlD
Ponatinib—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000698	0.00542	CcSEcCtD
Ponatinib—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000698	0.00542	CcSEcCtD
Ponatinib—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.000693	0.00538	CcSEcCtD
Ponatinib—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.000693	0.00538	CcSEcCtD
Ponatinib—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.000687	0.00534	CcSEcCtD
Ponatinib—FGFR2—liver—primary biliary cirrhosis	0.000686	0.00781	CbGeAlD
Ponatinib—Pancytopenia—Colchicine—primary biliary cirrhosis	0.000681	0.00529	CcSEcCtD
Ponatinib—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000674	0.00523	CcSEcCtD
Ponatinib—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000674	0.00523	CcSEcCtD
Ponatinib—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000671	0.00521	CcSEcCtD
Ponatinib—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000671	0.00521	CcSEcCtD
Ponatinib—Neutropenia—Colchicine—primary biliary cirrhosis	0.00067	0.00521	CcSEcCtD
Ponatinib—TEK—liver—primary biliary cirrhosis	0.000657	0.00749	CbGeAlD
Ponatinib—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000657	0.00511	CcSEcCtD
Ponatinib—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000657	0.00511	CcSEcCtD
Ponatinib—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000632	0.00491	CcSEcCtD
Ponatinib—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000632	0.00491	CcSEcCtD
Ponatinib—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.000628	0.00487	CcSEcCtD
Ponatinib—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.000628	0.00487	CcSEcCtD
Ponatinib—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.000627	0.00487	CcSEcCtD
Ponatinib—Stomatitis—Colchicine—primary biliary cirrhosis	0.000623	0.00484	CcSEcCtD
Ponatinib—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000618	0.0048	CcSEcCtD
Ponatinib—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000618	0.0048	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000599	0.00465	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000599	0.00465	CcSEcCtD
Ponatinib—PDGFRA—liver—primary biliary cirrhosis	0.000596	0.00678	CbGeAlD
Ponatinib—SRC—liver—primary biliary cirrhosis	0.000584	0.00665	CbGeAlD
Ponatinib—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000583	0.00453	CcSEcCtD
Ponatinib—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000583	0.00453	CcSEcCtD
Ponatinib—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000578	0.00449	CcSEcCtD
Ponatinib—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000578	0.00449	CcSEcCtD
Ponatinib—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00446	CcSEcCtD
Ponatinib—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00446	CcSEcCtD
Ponatinib—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00446	CcSEcCtD
Ponatinib—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00446	CcSEcCtD
Ponatinib—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.000571	0.00444	CcSEcCtD
Ponatinib—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.000566	0.0044	CcSEcCtD
Ponatinib—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.000566	0.0044	CcSEcCtD
Ponatinib—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000563	0.00437	CcSEcCtD
Ponatinib—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000563	0.00437	CcSEcCtD
Ponatinib—Jaundice—Chenodeoxycholic acid—primary biliary cirrhosis	0.00056	0.00435	CcSEcCtD
Ponatinib—Jaundice—Ursodeoxycholic acid—primary biliary cirrhosis	0.00056	0.00435	CcSEcCtD
Ponatinib—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000558	0.00434	CcSEcCtD
Ponatinib—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000558	0.00434	CcSEcCtD
Ponatinib—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.000543	0.00422	CcSEcCtD
Ponatinib—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.000543	0.00422	CcSEcCtD
Ponatinib—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000542	0.00421	CcSEcCtD
Ponatinib—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000542	0.00421	CcSEcCtD
Ponatinib—KDR—liver—primary biliary cirrhosis	0.000537	0.00612	CbGeAlD
Ponatinib—Eye disorder—Colchicine—primary biliary cirrhosis	0.000536	0.00417	CcSEcCtD
Ponatinib—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000518	0.00403	CcSEcCtD
Ponatinib—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000518	0.00403	CcSEcCtD
Ponatinib—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000517	0.00402	CcSEcCtD
Ponatinib—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000516	0.00401	CcSEcCtD
Ponatinib—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000516	0.00401	CcSEcCtD
Ponatinib—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000508	0.00395	CcSEcCtD
Ponatinib—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000508	0.00395	CcSEcCtD
Ponatinib—Alopecia—Colchicine—primary biliary cirrhosis	0.000507	0.00394	CcSEcCtD
Ponatinib—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000507	0.00394	CcSEcCtD
Ponatinib—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000507	0.00394	CcSEcCtD
Ponatinib—Malnutrition—Colchicine—primary biliary cirrhosis	0.0005	0.00388	CcSEcCtD
Ponatinib—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.000497	0.00386	CcSEcCtD
Ponatinib—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.000497	0.00386	CcSEcCtD
Ponatinib—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000482	0.00374	CcSEcCtD
Ponatinib—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000482	0.00374	CcSEcCtD
Ponatinib—Muscle spasms—Colchicine—primary biliary cirrhosis	0.00048	0.00373	CcSEcCtD
Ponatinib—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000479	0.00372	CcSEcCtD
Ponatinib—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000479	0.00372	CcSEcCtD
Ponatinib—KIT—liver—primary biliary cirrhosis	0.000476	0.00542	CbGeAlD
Ponatinib—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000468	0.00363	CcSEcCtD
Ponatinib—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000468	0.00363	CcSEcCtD
Ponatinib—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000465	0.00361	CcSEcCtD
Ponatinib—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000465	0.00361	CcSEcCtD
Ponatinib—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000463	0.00359	CcSEcCtD
Ponatinib—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000463	0.00359	CcSEcCtD
Ponatinib—Anaemia—Colchicine—primary biliary cirrhosis	0.000462	0.00359	CcSEcCtD
Ponatinib—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000461	0.00358	CcSEcCtD
Ponatinib—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000461	0.00358	CcSEcCtD
Ponatinib—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000456	0.00354	CcSEcCtD
Ponatinib—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000456	0.00354	CcSEcCtD
Ponatinib—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000449	0.00349	CcSEcCtD
Ponatinib—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000449	0.00349	CcSEcCtD
Ponatinib—Leukopenia—Colchicine—primary biliary cirrhosis	0.000447	0.00347	CcSEcCtD
Ponatinib—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000434	0.00337	CcSEcCtD
Ponatinib—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000434	0.00337	CcSEcCtD
Ponatinib—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000432	0.00335	CcSEcCtD
Ponatinib—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000432	0.00335	CcSEcCtD
Ponatinib—Arthralgia—Colchicine—primary biliary cirrhosis	0.000425	0.0033	CcSEcCtD
Ponatinib—Myalgia—Colchicine—primary biliary cirrhosis	0.000425	0.0033	CcSEcCtD
Ponatinib—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000415	0.00322	CcSEcCtD
Ponatinib—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000415	0.00322	CcSEcCtD
Ponatinib—ABL1—liver—primary biliary cirrhosis	0.000415	0.00472	CbGeAlD
Ponatinib—Imatinib—ALB—primary biliary cirrhosis	0.000414	0.166	CrCbGaD
Ponatinib—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000402	0.00312	CcSEcCtD
Ponatinib—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000402	0.00312	CcSEcCtD
Ponatinib—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.0004	0.00311	CcSEcCtD
Ponatinib—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000399	0.0031	CcSEcCtD
Ponatinib—Skin disorder—Colchicine—primary biliary cirrhosis	0.000396	0.00308	CcSEcCtD
Ponatinib—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000392	0.00304	CcSEcCtD
Ponatinib—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000392	0.00304	CcSEcCtD
Ponatinib—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000388	0.00301	CcSEcCtD
Ponatinib—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000388	0.00301	CcSEcCtD
Ponatinib—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000382	0.00297	CcSEcCtD
Ponatinib—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000382	0.00297	CcSEcCtD
Ponatinib—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000382	0.00297	CcSEcCtD
Ponatinib—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000382	0.00297	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00038	0.00295	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00038	0.00295	CcSEcCtD
Ponatinib—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000374	0.0029	CcSEcCtD
Ponatinib—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000374	0.0029	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000371	0.00289	CcSEcCtD
Ponatinib—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00285	CcSEcCtD
Ponatinib—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00285	CcSEcCtD
Ponatinib—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000364	0.00283	CcSEcCtD
Ponatinib—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000364	0.00283	CcSEcCtD
Ponatinib—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000359	0.00279	CcSEcCtD
Ponatinib—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000359	0.00279	CcSEcCtD
Ponatinib—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000359	0.00279	CcSEcCtD
Ponatinib—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000359	0.00279	CcSEcCtD
Ponatinib—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000356	0.00276	CcSEcCtD
Ponatinib—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000356	0.00276	CcSEcCtD
Ponatinib—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000354	0.00275	CcSEcCtD
Ponatinib—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000354	0.00275	CcSEcCtD
Ponatinib—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000354	0.00275	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000352	0.00273	CcSEcCtD
Ponatinib—Fatigue—Colchicine—primary biliary cirrhosis	0.000352	0.00273	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000334	0.00259	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000334	0.00259	CcSEcCtD
Ponatinib—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000333	0.00259	CcSEcCtD
Ponatinib—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000331	0.00257	CcSEcCtD
Ponatinib—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000331	0.00257	CcSEcCtD
Ponatinib—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000329	0.00256	CcSEcCtD
Ponatinib—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000329	0.00256	CcSEcCtD
Ponatinib—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000327	0.00254	CcSEcCtD
Ponatinib—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000327	0.00254	CcSEcCtD
Ponatinib—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000322	0.0025	CcSEcCtD
Ponatinib—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000322	0.0025	CcSEcCtD
Ponatinib—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000322	0.0025	CcSEcCtD
Ponatinib—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000318	0.00247	CcSEcCtD
Ponatinib—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000318	0.00247	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000316	0.00246	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000316	0.00246	CcSEcCtD
Ponatinib—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000316	0.00245	CcSEcCtD
Ponatinib—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000316	0.00245	CcSEcCtD
Ponatinib—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000313	0.00243	CcSEcCtD
Ponatinib—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000313	0.00243	CcSEcCtD
Ponatinib—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000313	0.00243	CcSEcCtD
Ponatinib—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000313	0.00243	CcSEcCtD
Ponatinib—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.0003	0.00233	CcSEcCtD
Ponatinib—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.0003	0.00233	CcSEcCtD
Ponatinib—Asthenia—Colchicine—primary biliary cirrhosis	0.000293	0.00227	CcSEcCtD
Ponatinib—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00029	0.00225	CcSEcCtD
Ponatinib—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00029	0.00225	CcSEcCtD
Ponatinib—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00029	0.00225	CcSEcCtD
Ponatinib—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00029	0.00225	CcSEcCtD
Ponatinib—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000279	0.00217	CcSEcCtD
Ponatinib—CYP2C8—liver—primary biliary cirrhosis	0.000269	0.00306	CbGeAlD
Ponatinib—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000263	0.00204	CcSEcCtD
Ponatinib—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000263	0.00204	CcSEcCtD
Ponatinib—ABCG2—liver—primary biliary cirrhosis	0.000261	0.00298	CbGeAlD
Ponatinib—Vomiting—Colchicine—primary biliary cirrhosis	0.000259	0.00201	CcSEcCtD
Ponatinib—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000259	0.00201	CcSEcCtD
Ponatinib—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000259	0.00201	CcSEcCtD
Ponatinib—Rash—Colchicine—primary biliary cirrhosis	0.000257	0.002	CcSEcCtD
Ponatinib—Dermatitis—Colchicine—primary biliary cirrhosis	0.000257	0.00199	CcSEcCtD
Ponatinib—Headache—Colchicine—primary biliary cirrhosis	0.000255	0.00198	CcSEcCtD
Ponatinib—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000251	0.00195	CcSEcCtD
Ponatinib—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000251	0.00195	CcSEcCtD
Ponatinib—CYP3A5—liver—primary biliary cirrhosis	0.000243	0.00276	CbGeAlD
Ponatinib—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000242	0.00188	CcSEcCtD
Ponatinib—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000242	0.00188	CcSEcCtD
Ponatinib—Nausea—Colchicine—primary biliary cirrhosis	0.000242	0.00188	CcSEcCtD
Ponatinib—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000233	0.00181	CcSEcCtD
Ponatinib—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000233	0.00181	CcSEcCtD
Ponatinib—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000231	0.00179	CcSEcCtD
Ponatinib—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000231	0.00179	CcSEcCtD
Ponatinib—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000231	0.00179	CcSEcCtD
Ponatinib—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000231	0.00179	CcSEcCtD
Ponatinib—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00023	0.00178	CcSEcCtD
Ponatinib—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00023	0.00178	CcSEcCtD
Ponatinib—ABCB1—epithelium—primary biliary cirrhosis	0.000227	0.00259	CbGeAlD
Ponatinib—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000218	0.00169	CcSEcCtD
Ponatinib—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000218	0.00169	CcSEcCtD
Ponatinib—CYP3A4—liver—primary biliary cirrhosis	0.000182	0.00207	CbGeAlD
Ponatinib—CYP2D6—liver—primary biliary cirrhosis	0.000179	0.00204	CbGeAlD
Ponatinib—ABCB1—liver—primary biliary cirrhosis	0.000129	0.00147	CbGeAlD
Ponatinib—LCK—Hemostasis—ALB—primary biliary cirrhosis	1.2e-05	9.42e-05	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—NFKB1—primary biliary cirrhosis	1.19e-05	9.41e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD79A—primary biliary cirrhosis	1.19e-05	9.4e-05	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—CD80—primary biliary cirrhosis	1.19e-05	9.4e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CCL5—primary biliary cirrhosis	1.19e-05	9.37e-05	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—PPARGC1A—primary biliary cirrhosis	1.19e-05	9.36e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD40LG—primary biliary cirrhosis	1.19e-05	9.35e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	1.18e-05	9.32e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD40LG—primary biliary cirrhosis	1.18e-05	9.31e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—TAB1—primary biliary cirrhosis	1.17e-05	9.23e-05	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.17e-05	9.2e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	1.17e-05	9.19e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	1.16e-05	9.17e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	1.16e-05	9.17e-05	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—MMP9—primary biliary cirrhosis	1.16e-05	9.14e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TYK2—primary biliary cirrhosis	1.15e-05	9.1e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—ELMO1—primary biliary cirrhosis	1.15e-05	9.09e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.15e-05	9.08e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.15e-05	9.03e-05	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.15e-05	9.03e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—AGT—primary biliary cirrhosis	1.14e-05	9e-05	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—MMP9—primary biliary cirrhosis	1.14e-05	8.99e-05	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—MMP9—primary biliary cirrhosis	1.14e-05	8.95e-05	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—NFKB1—primary biliary cirrhosis	1.13e-05	8.93e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—NFKB1—primary biliary cirrhosis	1.13e-05	8.9e-05	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—NFKB1—primary biliary cirrhosis	1.13e-05	8.89e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—HIF1A—primary biliary cirrhosis	1.13e-05	8.87e-05	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—NFKB1—primary biliary cirrhosis	1.12e-05	8.85e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—GOT2—primary biliary cirrhosis	1.12e-05	8.79e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CTLA4—primary biliary cirrhosis	1.11e-05	8.72e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—HIF1A—primary biliary cirrhosis	1.11e-05	8.71e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—MMP2—primary biliary cirrhosis	1.1e-05	8.68e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—CD80—primary biliary cirrhosis	1.1e-05	8.66e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	1.1e-05	8.64e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	1.1e-05	8.64e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.09e-05	8.62e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.09e-05	8.6e-05	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.09e-05	8.57e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—GOT1—primary biliary cirrhosis	1.09e-05	8.57e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.09e-05	8.55e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CD80—primary biliary cirrhosis	1.08e-05	8.48e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.07e-05	8.44e-05	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—ALB—primary biliary cirrhosis	1.06e-05	8.34e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—CD80—primary biliary cirrhosis	1.06e-05	8.33e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD79A—primary biliary cirrhosis	1.06e-05	8.32e-05	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CD80—primary biliary cirrhosis	1.06e-05	8.32e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TYK2—primary biliary cirrhosis	1.05e-05	8.28e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—HIF1A—primary biliary cirrhosis	1.05e-05	8.27e-05	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—TYK2—primary biliary cirrhosis	1.05e-05	8.26e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—HIF1A—primary biliary cirrhosis	1.05e-05	8.25e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—TAB1—primary biliary cirrhosis	1.04e-05	8.17e-05	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	1.04e-05	8.16e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—CTGF—primary biliary cirrhosis	1.03e-05	8.13e-05	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—NFKB1—primary biliary cirrhosis	1.03e-05	8.11e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—NOS2—primary biliary cirrhosis	1.02e-05	8.07e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—GOT2—primary biliary cirrhosis	1.02e-05	8.06e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.02e-05	8.01e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.01e-05	7.99e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CD80—primary biliary cirrhosis	1.01e-05	7.97e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—NOS2—primary biliary cirrhosis	1.01e-05	7.93e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CD80—primary biliary cirrhosis	1e-05	7.9e-05	CbGpPWpGaD
Ponatinib—ABCG2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1e-05	7.9e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CD80—primary biliary cirrhosis	1e-05	7.88e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—HIF1A—primary biliary cirrhosis	9.99e-06	7.87e-05	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—NFKB1—primary biliary cirrhosis	9.97e-06	7.85e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MMP3—primary biliary cirrhosis	9.95e-06	7.84e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—AGT—primary biliary cirrhosis	9.95e-06	7.84e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—CD80—primary biliary cirrhosis	9.94e-06	7.83e-05	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—NFKB1—primary biliary cirrhosis	9.92e-06	7.82e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MMP3—primary biliary cirrhosis	9.77e-06	7.7e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—CD80—primary biliary cirrhosis	9.76e-06	7.69e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD40LG—primary biliary cirrhosis	9.73e-06	7.66e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—GOT1—primary biliary cirrhosis	9.63e-06	7.59e-05	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—NFKB1—primary biliary cirrhosis	9.57e-06	7.54e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—NOS2—primary biliary cirrhosis	9.55e-06	7.52e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—NOS2—primary biliary cirrhosis	9.52e-06	7.5e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CCL5—primary biliary cirrhosis	9.39e-06	7.4e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—TYK2—primary biliary cirrhosis	9.28e-06	7.31e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MMP3—primary biliary cirrhosis	9.27e-06	7.31e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—NUP210—primary biliary cirrhosis	9.27e-06	7.3e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CD80—primary biliary cirrhosis	9.26e-06	7.3e-05	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—AGT—primary biliary cirrhosis	9.25e-06	7.29e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MMP3—primary biliary cirrhosis	9.25e-06	7.29e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CD80—primary biliary cirrhosis	9.24e-06	7.28e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CCL5—primary biliary cirrhosis	9.22e-06	7.27e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	9.1e-06	7.17e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—MMP9—primary biliary cirrhosis	9.09e-06	7.17e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—TYK2—primary biliary cirrhosis	9.09e-06	7.16e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—NFKB1—primary biliary cirrhosis	9e-06	7.09e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CXCL10—primary biliary cirrhosis	8.95e-06	7.05e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	8.94e-06	7.04e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—TYK2—primary biliary cirrhosis	8.92e-06	7.03e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD80—primary biliary cirrhosis	8.83e-06	6.95e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—GGT1—primary biliary cirrhosis	8.83e-06	6.95e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—GOT1—primary biliary cirrhosis	8.83e-06	6.95e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CD80—primary biliary cirrhosis	8.81e-06	6.95e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD80—primary biliary cirrhosis	8.79e-06	6.92e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CCL5—primary biliary cirrhosis	8.75e-06	6.9e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CCL5—primary biliary cirrhosis	8.73e-06	6.88e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ABCG2—primary biliary cirrhosis	8.61e-06	6.79e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD40LG—primary biliary cirrhosis	8.61e-06	6.78e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	8.55e-06	6.74e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TYK2—primary biliary cirrhosis	8.54e-06	6.73e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	8.52e-06	6.72e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	8.48e-06	6.68e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—TYK2—primary biliary cirrhosis	8.47e-06	6.67e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	8.46e-06	6.67e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—TYK2—primary biliary cirrhosis	8.45e-06	6.66e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TYK2—primary biliary cirrhosis	8.39e-06	6.61e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—MMP9—primary biliary cirrhosis	8.28e-06	6.52e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—TYK2—primary biliary cirrhosis	8.24e-06	6.49e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—NFKB1—primary biliary cirrhosis	8.19e-06	6.45e-05	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—NFKB1—primary biliary cirrhosis	8.17e-06	6.44e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP3—primary biliary cirrhosis	8.16e-06	6.43e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—NUP210—primary biliary cirrhosis	8.03e-06	6.32e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—HIF1A—primary biliary cirrhosis	7.88e-06	6.21e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—AGT—primary biliary cirrhosis	7.86e-06	6.19e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PPARGC1A—primary biliary cirrhosis	7.85e-06	6.19e-05	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—NFKB1—primary biliary cirrhosis	7.85e-06	6.18e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TYK2—primary biliary cirrhosis	7.82e-06	6.16e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TYK2—primary biliary cirrhosis	7.8e-06	6.15e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—HIF1A—primary biliary cirrhosis	7.74e-06	6.1e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—AGT—primary biliary cirrhosis	7.72e-06	6.08e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CCL5—primary biliary cirrhosis	7.7e-06	6.07e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	7.62e-06	6.01e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—HIF1A—primary biliary cirrhosis	7.57e-06	5.96e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	7.46e-06	5.88e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ABCG2—primary biliary cirrhosis	7.46e-06	5.88e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—TYK2—primary biliary cirrhosis	7.45e-06	5.87e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TYK2—primary biliary cirrhosis	7.44e-06	5.86e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—TYK2—primary biliary cirrhosis	7.42e-06	5.84e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CTGF—primary biliary cirrhosis	7.39e-06	5.82e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—HIF1A—primary biliary cirrhosis	7.35e-06	5.79e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.33e-06	5.78e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—HIF1A—primary biliary cirrhosis	7.33e-06	5.78e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GOT2—primary biliary cirrhosis	7.33e-06	5.77e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—AGT—primary biliary cirrhosis	7.32e-06	5.77e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—AGT—primary biliary cirrhosis	7.3e-06	5.75e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD80—primary biliary cirrhosis	7.23e-06	5.7e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—NFKB1—primary biliary cirrhosis	7.23e-06	5.7e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	7.17e-06	5.65e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	7.17e-06	5.65e-05	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—ALB—primary biliary cirrhosis	7.1e-06	5.6e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—NFKB1—primary biliary cirrhosis	7.08e-06	5.58e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	6.99e-06	5.51e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CD80—primary biliary cirrhosis	6.96e-06	5.48e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—NFKB1—primary biliary cirrhosis	6.95e-06	5.48e-05	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—NFKB1—primary biliary cirrhosis	6.95e-06	5.47e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—NOS2—primary biliary cirrhosis	6.88e-06	5.42e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CD80—primary biliary cirrhosis	6.83e-06	5.39e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—MMP9—primary biliary cirrhosis	6.73e-06	5.3e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—HIF1A—primary biliary cirrhosis	6.7e-06	5.28e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP3—primary biliary cirrhosis	6.69e-06	5.27e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—CD80—primary biliary cirrhosis	6.68e-06	5.26e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—NFKB1—primary biliary cirrhosis	6.66e-06	5.24e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—NFKB1—primary biliary cirrhosis	6.6e-06	5.2e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	6.59e-06	5.19e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—NFKB1—primary biliary cirrhosis	6.58e-06	5.19e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	6.54e-06	5.15e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	6.5e-06	5.12e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CXCL10—primary biliary cirrhosis	6.49e-06	5.11e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CD80—primary biliary cirrhosis	6.49e-06	5.11e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CD80—primary biliary cirrhosis	6.47e-06	5.1e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—HIF1A—primary biliary cirrhosis	6.47e-06	5.09e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—AGT—primary biliary cirrhosis	6.44e-06	5.08e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD80—primary biliary cirrhosis	6.4e-06	5.05e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CTGF—primary biliary cirrhosis	6.4e-06	5.04e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GOT2—primary biliary cirrhosis	6.34e-06	5e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GGT1—primary biliary cirrhosis	6.32e-06	4.98e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GOT1—primary biliary cirrhosis	6.32e-06	4.98e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CCL5—primary biliary cirrhosis	6.31e-06	4.97e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	6.13e-06	4.83e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—AGT—primary biliary cirrhosis	6.12e-06	4.82e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.12e-06	4.82e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—TYK2—primary biliary cirrhosis	6.11e-06	4.81e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—NOS2—primary biliary cirrhosis	6.09e-06	4.8e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP3—primary biliary cirrhosis	5.92e-06	4.66e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—CD80—primary biliary cirrhosis	5.91e-06	4.66e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TYK2—primary biliary cirrhosis	5.87e-06	4.63e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—MMP9—primary biliary cirrhosis	5.86e-06	4.62e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—NFKB1—primary biliary cirrhosis	5.81e-06	4.57e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—NFKB1—primary biliary cirrhosis	5.8e-06	4.57e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—NFKB1—primary biliary cirrhosis	5.78e-06	4.55e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TYK2—primary biliary cirrhosis	5.77e-06	4.55e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CD80—primary biliary cirrhosis	5.71e-06	4.5e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—TYK2—primary biliary cirrhosis	5.64e-06	4.44e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PPARGC1A—primary biliary cirrhosis	5.63e-06	4.43e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCL5—primary biliary cirrhosis	5.59e-06	4.4e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	5.58e-06	4.39e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	5.53e-06	4.36e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GOT1—primary biliary cirrhosis	5.48e-06	4.32e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GGT1—primary biliary cirrhosis	5.48e-06	4.32e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TYK2—primary biliary cirrhosis	5.48e-06	4.31e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TYK2—primary biliary cirrhosis	5.46e-06	4.3e-05	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	5.42e-06	4.27e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	5.41e-06	4.27e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—TYK2—primary biliary cirrhosis	5.41e-06	4.26e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.3e-06	4.18e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—AGT—primary biliary cirrhosis	5.28e-06	4.16e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	5.26e-06	4.14e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	5.21e-06	4.1e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—TYK2—primary biliary cirrhosis	4.99e-06	3.93e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PPARGC1A—primary biliary cirrhosis	4.87e-06	3.84e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TYK2—primary biliary cirrhosis	4.82e-06	3.8e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	4.77e-06	3.76e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	4.77e-06	3.76e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—NFKB1—primary biliary cirrhosis	4.76e-06	3.75e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—ALB—primary biliary cirrhosis	4.69e-06	3.7e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.69e-06	3.7e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CD80—primary biliary cirrhosis	4.68e-06	3.69e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—AGT—primary biliary cirrhosis	4.67e-06	3.68e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MMP9—primary biliary cirrhosis	4.63e-06	3.65e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.58e-06	3.61e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MMP9—primary biliary cirrhosis	4.54e-06	3.58e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	4.5e-06	3.54e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	4.5e-06	3.54e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.5e-06	3.54e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—AGT—primary biliary cirrhosis	4.38e-06	3.45e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MMP9—primary biliary cirrhosis	4.31e-06	3.4e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	4.31e-06	3.39e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MMP9—primary biliary cirrhosis	4.3e-06	3.39e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.27e-06	3.36e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.26e-06	3.35e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	4.25e-06	3.35e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—NFKB1—primary biliary cirrhosis	4.21e-06	3.32e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CD80—primary biliary cirrhosis	4.14e-06	3.26e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	4.01e-06	3.16e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	4e-06	3.15e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TYK2—primary biliary cirrhosis	3.95e-06	3.11e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—AGT—primary biliary cirrhosis	3.8e-06	2.99e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP9—primary biliary cirrhosis	3.79e-06	2.99e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.75e-06	2.96e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TYK2—primary biliary cirrhosis	3.5e-06	2.75e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	3.44e-06	2.71e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	3.41e-06	2.68e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ALB—primary biliary cirrhosis	3.36e-06	2.65e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—AGT—primary biliary cirrhosis	3.31e-06	2.61e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	3.12e-06	2.46e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP9—primary biliary cirrhosis	3.11e-06	2.45e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.08e-06	2.42e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	2.94e-06	2.32e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	2.94e-06	2.32e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ALB—primary biliary cirrhosis	2.91e-06	2.3e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP9—primary biliary cirrhosis	2.75e-06	2.17e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.72e-06	2.15e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	2.62e-06	2.06e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ALB—primary biliary cirrhosis	2.54e-06	2e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	2.39e-06	1.88e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	2.04e-06	1.61e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	1.56e-06	1.23e-05	CbGpPWpGaD
